Consequently, TNFR2 has emerged as a promising therapeutic target, with current translational research efforts focused on developing biologics and small molecules to modulate TNFR2 activity in autoimmune diseases, GVHD, and cancer. The gene discussed is TNFRSF1B; the disease is cancer.